Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review

Alexy Hernandez,Leslie Zapata Leiva,Maria Mutka,Kathryn S. Torok,Leila Ledbetter and Christina K. Zigler

DOI: https://doi.org/10.1186/s12969-024-01014-x

2024-08-23

Pediatric Rheumatology

Abstract:Current treatment for localized scleroderma (LS) has been shown to halt disease activity, but little is still known about patient experiences with these treatments, nor is there consensus about optimal measurement strategies for future clinical trials.

pediatrics,rheumatology